SCHEMBL30348489

SCHEMBL30348489

Cc1nc2ccc(-c3c[nH]c4nc(NC5CCOCC5)ncc34)cc2s1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 3/20 0.44
▸ RET P07949 1/20 0.42
▸ MAPK1 P28482 4/20 0.42
▸ BRD4 O60885 2/20 0.40
▸ ABL1 P00519 1/20 0.40
▸ CLK2 P49760 3/20 0.40
▸ CDK2 P24941 2/20 0.40
▸ CDK7 P50613 2/20 0.40
▸ CDK9 P50750 2/20 0.40
▸ ROCK2 O75116 2/20 0.40
▸ CCNT1 O60563 1/20 0.40
▸ CCNC P24863 1/20 0.40
▸ CDK8 P49336 1/20 0.40
▸ CCNH P51946 1/20 0.40
▸ MNAT1 P51948 1/20 0.40
▸ CDC7 O00311 1/20 0.40
▸ DAPK3 O43293 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ PRKD3 O94806 1/20 0.40
▸ MAP4K4 O95819 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25158420 1.00 DYRK1A (0.44) DYRK1ARETMAPK1BRD4ABL1
SCHEMBL25158434 0.91 CDC7 (0.42) DYRK1ARETMAPK1BRD4ABL1
SCHEMBL30348692 0.88 DYRK1A (0.47) DYRK1ARETBRD4ABL1CLK2
SCHEMBL25158417 0.88 DYRK1A (0.47) DYRK1ARETBRD4ABL1CLK2
SCHEMBL25157917 0.87 BRD4 (0.39) DYRK1AMAPK1BRD4ABL1CLK2
SCHEMBL30348704 0.87 BRD4 (0.39) DYRK1AMAPK1BRD4ABL1CLK2
SCHEMBL25203199 0.87 RET (0.45) DYRK1ARETBRD4ABL1CLK2
SCHEMBL25266090 0.87 RET (0.45) DYRK1ARETBRD4ABL1CLK2
SCHEMBL25215131 0.86 ROCK2 (0.37) DYRK1ARETBRD4ABL1CLK2
SCHEMBL25215129 0.86 ROCK2 (0.37) DYRK1ARETBRD4ABL1CLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4415818-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS BioSplice Therapeutics, Inc. (US) 2024-08-21 — — EP claimed
WO-2023064361-A1 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS BIOSPLICE THERAPEUTICS, INC. (US) 2023-04-20 — — WO claimed
Send feedback